These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10645143)

  • 1. [Progress in research for new drugs against the herpes virus].
    Rostkowska-Nadolska B
    Postepy Hig Med Dosw; 1999; 53(5):675-87. PubMed ID: 10645143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiherpes virus agents: a review.
    Lapucci A; Macchia M; Parkin A
    Farmaco; 1993 Jul; 48(7):871-95. PubMed ID: 8397674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valacyclovir for the management of herpes viral infections.
    Chakrabarty A; Anderson NJ; Beutner R; Tyring SK
    Skin Therapy Lett; 2005 Feb; 10(1):1-4. PubMed ID: 15776202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-herpetic chemotherapeutic drugs].
    Shiraki K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():792-7. PubMed ID: 12722318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains.
    Gus'kova AA; Skoblov MY; Korovina AN; Yasko MV; Karpenko IL; Kukhanova MK; Andronova VL; Galegov GA; Skoblov YS
    Chem Biol Drug Des; 2009 Oct; 74(4):382-9. PubMed ID: 19691467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main adult herpes virus infections of the CNS.
    Denes E; Ranger-Rogez S
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):663-78. PubMed ID: 16107204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the chemotherapy of herpes virus infections.
    Eşanu V
    Virologie; 1981; 32(1):57-77. PubMed ID: 6191437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic nucleoside analogues as antiherpes agents.
    Golankiewicz B; Ostrowski T
    Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
    Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
    J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets.
    Coen DM; Schaffer PA
    Nat Rev Drug Discov; 2003 Apr; 2(4):278-88. PubMed ID: 12669027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
    Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
    Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
    Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the antiviral therapy of herpes virus infection in children.
    Luck S; Sharland M; Griffiths P; Jenkins SM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):1005-20. PubMed ID: 17181417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus: it's more than a cold sore.
    Swearingen JA; Ailor SK
    Mo Med; 2007; 104(2):144-8. PubMed ID: 17536444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.